Definium Therapeutics, Inc. (DFTX)
16.25
-1.10
(-6.34%)
USD |
NASDAQ |
Feb 12, 16:00
16.44
+0.19
(+1.17%)
After-Hours: 19:51
Definium Therapeutics EPS Diluted (Quarterly) : -0.7832 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | -0.2877 |
| RxSight, Inc. | -0.2396 |
| Plus Therapeutics, Inc. | -0.0412 |
| Viridian Therapeutics, Inc. | -0.423 |
| Nutriband, Inc. | -0.3212 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.26M |
| Total Expenses (Quarterly) | 67.26M |
| Enterprise Value | 1.540B |
| Earnings Yield | -12.14% |
| Normalized Earnings Yield | -11.00 |